Applications of CRISPR/Cas9 Technology in Translational Research on Solid-Tumor Cancers
Efforts Are Underway to Move CRISPR/Cas9 from Bench to Bedside
Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs
Summary of the Progress and Challenges in the Repurposing Kinase Inhibitors as Broad-Spectrum Antiviral Therapies
Genome Editing B.C. (Before CRISPR)
Lasting Lessons from the “Old Testament”
The Top 15 Best-Selling Drugs of 2017
Amid Talk of Curbing Prices, Most Treatments Show Sales Gains
For full access to this article login to GEN Select now.
Blood Can Replace Tissue Biopsies
Cynvenio Biosystems’ Diagnostic Platform Analyzes cDNA, Captures Cancer’s Dynamism
- Cynvenio Biosystems, with its LiquidBiopsy ® rare cell isolation and genomic analysis platform, is at the forefront of cancer diagnostics. Rather than rely on tissue biopsies or counting circulating tumor cells in the blood, this technology extracts and sequences those cells’ DNA. That, in turn, makes possible real-time analysis ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.